The Cardio-Renal-Hepatic Axis in MASLD. Role of BDNF, NGF, and Metabolic Cross-Talk

Lucy C. Taylor, Michael I. Adenawoola, Claire B. Wingfield, Maren K. Nadolski, David E. Stec · 2026

Read The Cardio-Renal-Hepatic Axis in MASLD. Role of BDNF, NGF, and Metabolic Cross-Talk by Lucy C. Taylor, Michael I. Adenawoola, Claire B. Wingfield, Maren K. Nadolski, David E. Stec (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13541824.txt.

Description

Lucy Taylor and co-authors review how fatty liver disease talks to the heart and kidneys, in a 2026 paper. In metabolic liver disease, fat in the liver rarely stays a liver problem: heart failure and kidney disease often follow. The review traces that three-way axis and the liver-born signals that carry it.

Fat overflow, inflamed fat around the heart, and clot-prone blood drive the cardiac damage, the authors argue. Two nerve growth signals from the liver stand out: one protective signal fades, shielding the heart and kidneys less, while growth factors from the liver play double roles in metabolism. New diabetes drugs that also protect heart and kidney fit the same story. Shared targets may treat the whole axis at once.

Catalog record

CREATORLucy C. Taylor, Michael I. Adenawoola, Claire B. Wingfield, Maren K. Nadolski, David E. Stec
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE79 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13541824

Browse the full library · About the Tower of Babel